NVEC.NASDAQNve CORP /NEW/

Form 4: NVE Corp Director James W. Bracke Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Director James W. Bracke reports acquisition of 1,000 non-qualified stock options in NVE Corp due to reelection to the Board of Directors.

Summary

  • On August 1, 2024, James W. Bracke, a director of NVE Corp, reported the acquisition of 1,000 non-qualified stock options.
  • These options were granted automatically upon his reelection to NVE's Board of Directors.
  • The exercise price of the options is $83.80.
  • The options are exercisable from August 1, 2024, and expire on August 1, 2034.
  • Following the transaction, Mr. Bracke directly owns 4,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects a standard corporate governance practice of incentivizing directors through stock options. The automatic grant upon reelection suggests stability and alignment.

Positives

  • The grant of stock options to a director aligns their interests with those of the shareholders.
  • Automatic grants upon reelection provide a consistent incentive for board members.

Industry Context

Stock option grants to directors are a common practice in corporate governance to incentivize and align their interests with shareholders. The specifics of the grant, such as the exercise price and vesting schedule, are tailored to the company's compensation strategy.

Comparison to Industry Standards

  • Stock option grants are a standard component of director compensation packages across various industries.
  • Companies like Texas Instruments and Analog Devices also use stock options as part of their director compensation.
  • The specific number of options and exercise price vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

  • The stock option grant aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
08/01/2024Date of transaction: acquisition of stock options and date exercisable
08/01/2034Expiration date of the stock options
08/02/2024Date of report filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.